key: cord-0788767-2h828q1j
authors: Adam, Abdel Majid A.; Saad, Hosam A.; Alsuhaibani, Amnah M.; Refat, Moamen S.; Hegab, Mohamed S.
title: Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part I: Complexation with iodine in different solvents
date: 2020-12-26
journal: J Mol Liq
DOI: 10.1016/j.molliq.2020.115187
sha: 6f75c1950d08ae5a56f3525f3003884f7112bf7a
doc_id: 788767
cord_uid: 2h828q1j

Around the world, the antibiotic azithromycin (AZM) is currently being used to treat the coronavirus disease (COVID-19) in conjunction with hydroxychloroquine or chloroquine. Investigating the chemical and physical properties of compounds used alone or in combination to combat the COVID-19 pandemic is of vital and pressing importance. The purpose of this study was to characterize the charge transfer (CT) complexation of AZM with iodine in four different solvents: CH(2)Cl(2), CHCl(3), CCl(4), and C(6)H(5)Cl. AZM reacted with iodine at a 1:1 M ratio (AZM to I(2)) in the CHCl(3) solvent and a 1:2 M ratio in the other three solvents, as evidenced by data obtained from an elemental analysis of the solid CT products and spectrophotometric titration and Job's continuous variation method for the soluble CT products. Data obtained from UV–visible and Raman spectroscopies indicated that AZM strongly interacted with iodine in the CH(2)Cl(2), CCl(4), and C(6)H(5)Cl solvents by a physically potent n→σ* interaction to produce a tri-iodide complex formulated as [AZM·I(+)]I(3)(−). XRD and TEM analyses revealed that, in all solvents, the AZM-I(2) complex possessed an amorphous structure composed of spherical particles ranging from 80 to 110 nm that tended to aggregate into clusters. The findings described in the present study will hopefully contribute to optimizing the treatment protocols for COVID-19.

All chemicals were procured from commercial chemical sources. The main chemicals used in this study were AZM powder (C 38 H 72 N 2 O 12 ; 748.98 g/mol;  98% Merck KGaA, Germany), iodine crystals (I 2 ; 253.81 g/mol;  99.8% Sigma-Aldrich, USA), and the following solvents (Merck KGaA, Germany): dichloromethane (CH 2 Cl 2 ;  99.8%), trichloromethane (CHCl 3 ;  99%), tetrachloromethane (CCl 4 ;  99.5%), and chlorobenzene (C 6 H 5 Cl; 99.8%). Safety precautions included using gloves, eye shields, and dust masks. Elemental analyses of nitrogen, hydrogen, and carbon are reported in percentages and were generated using a Perkin-Elmer CHN Microanalyzer (Model PE 2400 series II). The HACH LANGE GmbH UV/VIS Spectrophotometer (Model DR6000 Benchtop) was used to record the UV-visible spectra and spectrophotometric measurements in absorption mode from 200 nm to 800 nm with 1.0-cm path length optical quartz cells. A Shimadzu Fourier Transform Infrared Spectrophotometer (FT-IR, Model IR Tracer-100) was used to collect the FT-IR spectra in transmission mode from 400 cm -1 to 4000 cm -1 . A Bruker Fourier Transform Raman Spectrophotometer (Model MultiRAM Stand Alone; 50 mW laser) was used to collect the FT-Raman spectra in Raman intensity over mode from 50 cm -1 to 3600 cm -1 . The microscopic morphology of the complexes prepared in the different solvents was investigated using the JEOL Transmission Electron Microscope (TEM; Model JEM-1200EX II). TEM micrographs were collected at 100 kV. A Malvern Panalytical's X-ray Powder Diffractometer (Model X'Pert 3 MRD) was used to collect the XRD spectra from a diffraction angle (2 ) of 5 to 80 at a radiation wavelength () of 0.154056 nm.

Three methods were used to determine the stoichiometry of the AZM-I 2 interaction: i) Job's continuous variation method [168] , ii) spectrophotometric titration [169] of the soluble CT product, and iii) elemental analysis of the solid CT product. Standard solutions of AZM and I 2 at a concentration of 5.0×10 -4 M were prepared by dilution in the appropriate solvent (CH 2 Cl 2 , CHCl 3 , CCl 4 , and C 6 H 5 Cl) from their stock solutions (10×10 -3 M). All stock and standard solutions were stored in the dark 4 at all times. To determine the wavelength (nm) of the CT band (λ CT ), the UV-visible spectra of the CT complex as well as the free components (AZM and I 2 ) were scanned between 200 and 800 nm at room temperature in the appropriate solvent.

A series of 10 solutions in volumetric flasks (20 mL) containing AZM and I 2 at varied molar fractions (C AZM + C iodine ) was prepared in the appropriate solvent. The total concentration in each flask was kept constant. The 10 solutions were left at room temperature for 10 minutes to allow the reaction to reach equilibrium. Then, the absorbances of the developed colors were measured at λ CT against a similarly treated blank reagent. The measured absorbances were plotted against the corresponding molar fraction of iodine calculated using the equation: χ iodine = C iodine /(C AZM + C iodine ). The molar ratio of the AZM-I 2 interaction was determined from the resulting plot.

A series of 10 solutions in volumetric flasks (20 mL) containing AZM and I 2 with varied AZM to iodine molar ratios ranging from 1:4 to 4:1 were prepared in the appropriate solvent. The concentration of AZM in each flask was kept constant, while the concentration of I 2 varied. The 10 solutions were kept at room temperature for 10 minutes to allow the reaction to reach equilibrium. Then, the absorbance of each solution was measured at λ CT against a similarly treated blank reagent. The absorbance of each solution was plotted as a function of the corresponding iodine volume in the solution. The molar ratio of the AZM-I 2 interaction was determined from the resulting plot and compared with that obtained using Job's continuous variation method.

One mmol of AZM and two mmol of iodine were separately dissolved in 25 mL of CH 2 Cl 2 solvent. The two solutions were mixed and stirred thoroughly for 10 minutes on a magnetic stir plate at room temperature. The resulting light-browncolored solution was incubated at 4C for 24 h to fully complete the precipitation process. The resultant brown-colored precipitate was filtered from the solvent using Whatman 42 grade filter paper and recrystallized in the CH 2 Cl 2 solvent to increase its purity. One day later, the resulting precipitate was filtered from the solvent. The recrystallized product was washed three times with the least possible volume of CH 2 Cl 2 solvent and the collected product was vacuum dried over CaCl 2 (anhydrous) in a desiccator at room temperature for 48 h [160] [161] [162] [163] [170] [171] [172] [173] . This procedure was then repeated in the other solvents (CHCl 3 , CCl 4 , C 6 H 5 Cl). To verify the resultant AZM-I 2 product, a small amount was dissolved in CH 2 Cl 2 solvent to which a few drops of aqueous HCl acid was added. The iodine color was restored faintly, supporting the formation of the desired product. The iodine content in the product was determined by iodimetry titrations.

The soluble CT product was generated by mixing the AZM solution in the appropriate solvent (CH 2 Cl 2 , CHCl 3 , CCl 4 , or C 6 H 5 Cl) at a concentration of 5.0×10 -4 M with the iodine solution in the same solvent at the same concentration. The AZM solutions, regardless of solvent, were colorless, while the iodine solution in all of the 5 solvents had a violet color. The resulting soluble CT products had an intense brown color in the CH 2 Cl 2 , CCl 4 , and C 6 H 5 Cl solvents; this type of color change resulted from the π-π interactions and provides evidence of a strong CT interaction. Figure 1 shows the prominent change in color upon mixing AZM with iodine in the CH 2 Cl 2 solvent (as an example). The solid CT product was generated by reacting 1 mmol of AZM (white) with 2 mmol of iodine (dark grey) in the appropriate solvent (CH 2 Cl 2 , CHCl 3 , CCl 4 , or C 6 H 5 Cl). As an example, this interaction in the CH 2 Cl 2 solvent resulted in a strong color change in forming the brown-colored solid CT, as pictured in Figure 2 . The strong change in color resulting from the complexation of AZM with iodine into either soluble or solid products confirms that the CT interaction between the two components took place in all of the solvents used.

The electronic absorption spectrum of free AZM (5.0×10 -4 M), free iodine (5.0×10 -4 M), and the CT complex resulting from mixing the two solutions in the CH 2 Cl 2 , CHCl 3 , CCl 4 , or C 6 H 5 Cl solvents were scanned in UV-visible region ( Figure  3 ). Characteristic spectral changes were observed upon the formation of the CT complex in each solvent, as seen in Figure 3 , this figure calls for the following observations: i) Free AZM displays no detectable absorption band in any solvent. ii) Free iodine displays a weak yet broad absorption band ranging from 430 nm to 620 nm in all solvents, with maximum absorption observed at 505 nm for the CH 2 Cl 2 and C 6 H 5 Cl solvents, 510 nm for the CHCl 3 solvent, and 517 nm for the CCl 4 solvent. This is the characteristic "iodine band" arising from the 410* electronic transition.

iii) The CT interaction between AZM and iodine in the CHCl 3 solvent strongly affected the characteristic iodine band, which became very broad and strong in this solvent and was unnoticeable in the other solvents. iv) The CT interaction between AZM and iodine in the CH 2 Cl 2 , CCl 4 , and C 6 H 5 Cl solvents gave rise to two new very strong, broad absorption bands. The first band was observed at 297 nm in all three solvents, while the second band was located at 364 nm in the CH 2 Cl 2 and C 6 H 5 Cl solvents and 372 nm in the CCl 4 solvent. v) The absorption band observed at 297 nm was caused by the iodide ion (I   -) . This iodide ion was associated with the formation of an inner complex formulated as

vi) The absorption band at ~364-372 nm was caused by the rapid formation of a triiodide ion (I 3 -) in solution from the CT complexation. This blue-shifted iodine band is the characteristic absorption band of the asymmetric tri-iodide ion (I 3 -) resulting from the formation of the AZM-I 2 complex [157, 160, 162] . The iodine band observed in the free iodine solution (505 nm for the CH 2 Cl 2 and C 6 H 5 Cl solvents and 517 nm for the CCl 4 solvent) hypsochromically shifted to 364-372 nm upon the addition of the AZM solution. This blue-shifted iodine band could reflect a perturbation in the iodine's 10* molecular orbital due to a repulsive interaction between the iodine and AZM [147] .

J o u r n a l P r e -p r o o f 6

The stoichiometry of the AZM-I 2 interaction was verified using Job's continuous variation method and the spectrophotometric titration method for the soluble CT products synthesized in each solvent. Figure 4 illustrates the curves generated by applying both methods. In Job's continuous variation method, plotting the molar fractions of iodine on the (x) axis against the absorbances at λ 510 (CHCl 3 ), 364 (CH 2 Cl 2 and C 6 H 5 Cl), or 372 nm (CCl 4 ) of the solutions prepared with different AZM to iodine molar fractions on the (y) axis gave a symmetrical curve (Figure 4 ). For this curve, the maximum absorbance corresponded to a molar fraction of 0.50 for the complex prepared in the CHCl 3 solvent and 0.33 for the complexes prepared in the other solvents. These molar fractions reflect the formation of a 1:1 AZM-I 2 complex in the CHCl 3 solvent and a 1:2 AZM-I 2 complex in the CH 2 Cl 2 , CCl 4 , and C 6 H 5 Cl solvents. In the spectrophotometric titration, plotting iodine volumes (in mL) on the (x) axis against the absorbances at λ 510 (CHCl 3 ), 364 (CH 2 Cl 2 and C 6 H 5 Cl), or 372 nm (CCl 4 ) of solutions prepared with different AZM to iodine molar ratios on the (y) axis gave two straight lines ( Figure 4 ). The intersection of these two straight lines corresponded to an iodine volume of 1.0 mL for the complex prepared in the CHCl 3 solvent and 2.0 mL for the complexes prepared in the other solvents. These volumes correspond to an AZM to iodine ratio of 1:1 in the CHCl 3 solvent and 1:2 in the other solvents.

The stoichiometry of the AZM-I 2 interaction was verified by the elemental analysis of the solid CT products. The elemental results for the solid CT product prepared in the CHCl 3 solvent were: C 38 (40.40) . These results suggested that the AZM-I 2 interaction in the CHCl 3 solvent formed a complex with the formula AZM·I 2 at a molar ratio of 1:1 and, in the other three solvents, complexes with the formula [AZM·I + ]I 3 were generated at a molar ratio of 1:2.

The UV-visible spectral data support the strong interaction between AZM and I 2 achieved through CT complexation in the CH 2 Cl 2 , CCl 4 , and C 6 H 5 Cl solvents. In these solvents, CT complexation proceeded through the formation of an asymmetric tri-iodide ion (I 3 -), as evidenced by the appearance of a band at 364-372 nm that is characteristic of the I 3 ion. The formation mechanism of the I 3 ion involves three steps [1, [157] [158] [159] [160] [161] [162] :

Step 1:

One AZM molecule fast reacted with one I 2 molecule to form an initially associative outer-sphere complex according to the following equation: AZM + I 2  AZM· I 2

Step 2:

The resulting outer-sphere complex (AZM· I 2 ) slowly transferred into a dissociative inner-sphere complex according to the following equation The absorption band characteristic of the I 3 ion was not detected when the CT complexation proceeded in the CHCl 3 solvent. In this solvent, AZM and I 2 reacted to form a CT complex formulated as AZM·I 2

Spectroscopic parameters like the standard free energy (G°), the resonance energy (R N ), the oscillator strength (f), the ionization potential (I P ), the transition dipole moment (), the energy of interaction (E CT ), the formation constant (K CT ), the molar extinction coefficient ( max ), and the dissociation energy (W) were calculated for the AZM-I 2 complex in each solvent at room temperature using the 1:1 and 1:2 Benesi-Hildebrand plots ( Figure 5 ) and equations described elsewhere [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] . The spectroscopic parameters for the AZM-I 2 complex in each solvent are tabulated in Table 1 . The AZM-I 2 complex had a high K CT in the CH 2 Cl 2 , CCl 4 , and CH 5 Cl solvents, suggesting that this complex is highly stable and strongly bounded [185] .

The value of G° was negative, suggesting that the complexation between AZM and I 2 in all solvents was reasonably stable, spontaneous, and exothermic [186] . The AZM-I 2 complex exhibited the highest values of K CT and G° in the CCl 4 solvent compared with the other three solvents. The values of these two parameters for the complex decreases in the solvents in the following order: CCl 4  C 6 H 5 Cl  CH 2 Cl 2  CHCl 3 . Figure 6 contains the FTIR spectra of free AZM and the CT complex prepared in the CH 2 Cl 2 solvent collected from 4000 to 400 cm -1 . The characteristic IR bands of free AZM listed in Table 2 are:

The OH groups of the AZM molecule gave rise to three vibrational modes: out-of-plane bending, in-plane bending, and stretching vibrations; these were observed at 731, 898, and 34963238 cm -1 , respectively [187] .

The bands corresponding to the four vibrational modes of methyl (CH 3 ) groups,  as (CH 3 ),  s (CH 3 ),  sciss (CH 3 ), and  rock (CH 3 ), were located at 2972, 2887, 1450, and 832 cm -1 , respectively. The bands resulting from the six vibrational modes of methylene (CH 2 ) groups,  twist (CH 2 ),  wag (CH 2 ),  rock (CH 2 ),  sciss (CH 2 ),  s (CH 2 ), and  as (CH 2 ), appeared at 560, 794, 1260, 1374, 2830, and 2932 cm -1 , respectively [188] [189] [190] . 

The two characteristic absorption bands resulting from C=O vibrations were observed at 1718 and 1660 cm -1 due to the  as (C=O) and  s (C=O) vibrational modes, respectively. The former (asymmetric mode) appeared as a sharp, medium-strong band, while the latter (symmetric vibrational mode) was broad and weak.

The bands resonating at 1175, 1088, 1040, and 984 cm -1 were associated with the  as (CN),  s (CN), (CO), and (CC) vibrational modes, respectively [191] . Among these, the band resulting from the (CO) vibration was very strong and sharp.

The FTIR spectrum of the CT complex contained absorption bands at 3355, 1720, 1626, 1169, 1046, 1000, and 950 cm -1 , which originated, respectively, from the stretching vibrations of (OH),  as (C=O),  s (C=O),  as (CN),  s (CN), (CO), and (CC). The IR spectra of the complex contained all of the principle bands for the AZM molecule with several complexation-associated changes in their intensities. The most notable change was observed in the ν(CO) and ν(OH) vibrations; these two bands were most affected by the CT complexation with iodine. The complexation with iodine decreased the intensity of the band resulting from the CO bonds with a slight shift in position from 1040 to 1000 cm -1 . The shape and position of the band originating from the (OH) vibration was also affected; this band became wider and shifted from 3486 cm -1 to 3355 cm -1 upon complexation. The broadening indicates the formation of intermolecular Hbonding between the OH group and triiodide ion ( The concurrent broadening and shift observed for the band characteristic of the ν(OH) vibration suggested that one or more of the OH groups in the AZM molecule may undergo Hbroadening and participate in the CT interaction with the I 2 molecule. Table 2 . FTIR frequencies with their tentative vibrational assignments for free AZM and the CT complex prepared in the CH 2 Cl 2 solvent.

Valuable information on the structural features of polyiodide anions can be obtained using Raman spectroscopy. Maki and Forneris [192] reported that the bands observed at 161 and 111 cm -1 in the Raman spectrum of I 3 correspond to the asymmetric and symmetric stretching vibrations, respectively. The laser Raman spectrum of the AZM-I 2 complex prepared in the CH 2 Cl 2 solvent, presented in Figure  7 , contained three bands at 70, 108, and 156 cm -1 reflective of the (I 3 -),  s (II), and  as (II) modes, respectively [192] [193] [194] [195] . These three bands are characteristic of the triiodide ion (I 3 -), which confirmed that the CT complexation between AZM and I 2 in the CH 2 Cl 2 solvent proceeded through the formation of an asymmetric triiodide ion (I 3 -), thus supporting the data obtained by UV-visible spectroscopy. According to ); A 1 ,  s (II); B 2 , and  as (II); A 1 ; these three motions are active in IR and Raman spectroscopy near 80, 100120, and 130155 cm -1 , respectively [196] [197] [198] [199] [200] [201] [202] .

The solid CT products prepared in the CH 2 Cl 2 , CHCl 3 , CCl 4 , and C 6 H 5 Cl solvents were examined by powder XRD spectroscopy to determine the framework structure and phase purity of these products. The solid products were ground into powders and scanned from a diffraction angle (2 ) of 5 to 80; the resultant spectra are presented in Figure 8 . The AZM-I 2 complexes prepared in the CH 2 Cl 2 , CCl 4 , and C 6 H 5 Cl solvents exhibited similar XRD patterns marked by one broad peak ranging from 2 13 to 30 and centered at approximately 20. The profile of the complex prepared in the CHCl 3 solvent displayed a much broader peak ranging from 2 17 to 50 centered at a 2 of approximately 37. The absence of a sharp and intense diffraction pattern suggests that the solid CT products possess an amorphous structure.

The solid CT products prepared in the CH 2 Cl 2 , CHCl 3 , CCl 4 , and C 6 H 5 Cl solvents were visualized with TEM to observe both the shape and size of their particles. Figures S1, S2 , S3, and S4 contain the TEM images of the AZM-I 2 complex prepared in the CH 2 Cl 2 , CHCl 3 , CCl 4 , and C 6 H 5 Cl solvents, respectively. The TEM images were captured at 6,000x to 30,000x magnification with an accelerating voltage of 100 kV. TEM imaging revealed the high similarity in the particles' morphology even when generated in different solvents. The particles from the complexes generated in every solvent were spherical, ranged in diameter from 80 to 110 nm, and tended to aggregate into big clusters.

The most pressing issue facing the world in 2020 and 2021 is finding a cure or vaccine for COVID-19. One of the current treatment protocols, subject to continuous examination and evaluation, is based on the antibiotic azithromycin (AZM) in combination with hydroxychloroquine or chloroquine. Providing new insight into the chemistry of this antibiotic may help researchers to improve such treatment protocols. Here we describe the CT interaction between AZM as a donor and iodine as an acceptor in four different solvents. Color changes visible to the naked eye were seen when AZM formed soluble and solid products with iodine. This type of color change is indicative of a strong CT interaction. UV-visible and Raman spectroscopies established that the CT interaction between AZM and iodine in the CH 2 Cl 2 , CHCl 4 , and C 6 H 5 Cl solvents formed a tri-iodide complex formulated as [AZM·I + ]I 3 -. The XRD and TEM experimental data support that that the AZMI 2 complex prepared in all of the solvents possessed an amorphous structure composed of spherical particles 80 to 110 nm in size. The results obtained from this work provide the basis for future investigations into the CT interactions between AZM and other types of acceptors in addition to furnishing a big picture perspective on the CT chemistry of AZM. 

 CT interaction between azithromycin and iodine was investigated.  Complex structures were characterized using several physicochemical techniques.  Striking color changes were observed in both soluble and solid forms.  This CT interaction occurred through the formation of a tri-iodide complex. 

Molecular Complexes

Organic Charge-Transfer Complexes

Charge Transfer Complexes in Biochemistry Systems

WHO director-General's opening remarks at the media briefing on COVID-19

Principle of Instrumental Analysis

Solvent effects in radical ion formation

Inorganic Electronic Spectroscopy

Assignments for Vibrational Spectra of Seven Hundred Benzene Derivatives

Vibrational Spectroscopy-Theory and Applications

Infrared and Raman Characteristic Group Frequencies-Tables and Charts

Spectrometric Identification of Organic Compounds